文献速递中毒与环境急症消化、代谢与肾脏急症

2023年国际对乙酰氨基酚大量过量治疗调查

An international survey of the treatment of massive paracetamol overdose in 2023.
PubMed 文献 · Clin Toxicol (Phila) · 2023-12-19
一句话结论国际调查显示,对乙酰氨基酚大量过量时61%的医生会增加乙酰半胱氨酸剂量,47%使用甲吡唑,28%推荐体外清除,但实践差异大且证据有限。

该横断面调查评估了31个国家342名医学毒理学提供者对假设性对乙酰氨基酚大量过量患者的处理模式。61%的提供者会增加乙酰半胱氨酸剂量,其中30%推荐在负荷量后以12.5 mg/kg/小时无限期输注,20%推荐Hendrickson方案(根据Rumack-Matthew列线图300 mg/L、400 mg/L和600 mg/L线逐步增加剂量),10%表示会给「双倍剂量乙酰半胱氨酸」但未说明具体含义。47%的提供者会使用甲吡唑,28%推荐体外清除。作者结论认为,非大量和大量对乙酰氨基酚过量的治疗在国际上存在相当大的差异,需要未来研究确定并标准化最有效的治疗。

要点

  • 在假设性对乙酰氨基酚大量过量场景中,61%的提供者会增加乙酰半胱氨酸剂量,但具体方案差异大。
  • 30%的提供者推荐在负荷量后以12.5 mg/kg/小时无限期输注乙酰半胱氨酸,20%推荐Hendrickson方案(按Rumack-Matthew列线图300、400、600 mg/L线逐步增加剂量)。
  • 47%的提供者会使用甲吡唑,28%推荐体外清除,但这些策略的获益在很大程度上仍是理论性的,人类疗效证据稀少。
  • 作者结论指出,非大量和大量对乙酰氨基酚过量的治疗在国际上存在相当大的差异,未来需要研究确定并标准化最有效的治疗。

适用人群与场景

  • 假设性对乙酰氨基酚大量过量患者;调查对象为国际医学毒理学提供者。

处置流程与药物剂量

  • 61%的提供者在治疗假设性大量过量时会增加乙酰半胱氨酸剂量。
  • 30%的受访者推荐在负荷量后以12.5 mg/kg/小时无限期输注乙酰半胱氨酸。
  • 20%的受访者推荐遵循「Hendrickson」方案,该方案主张根据Rumack-Matthew列线图上300 mg/L、400 mg/L和600 mg/L线的高对乙酰氨基酚浓度逐步增加乙酰半胱氨酸剂量。
  • 10%的受访者表示会给予「双倍剂量乙酰半胱氨酸」,但未说明具体含义。
  • 47%的受访者表示会使用甲吡唑。
  • 28%的受访者推荐体外清除。

研究设计与关键结果

  • 研究类型:横断面研究,调查国际医学毒理学提供者对假设性对乙酰氨基酚大量过量患者的处理模式。
  • 研究期间共获得来自31个不同国家的342份回复。
  • 61%的提供者在治疗假设性大量过量时会增加乙酰半胱氨酸剂量;30%推荐负荷量后12.5 mg/kg/小时无限期输注;20%推荐Hendrickson方案;10%表示会给予「双倍剂量乙酰半胱氨酸」但未说明具体含义。
  • 47%的受访者表示会使用甲吡唑;28%的受访者推荐体外清除。

证据类型、等级与局限

  • 证据类型:横断面调查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 调查显示,对乙酰氨基酚大量过量时多数提供者会增加乙酰半胱氨酸剂量,近半数会加用甲吡唑,近三分之一会采用体外清除,但具体方案在国际上存在相当大的差异。
  • 作者结论认为,未来需要研究以确定并标准化非大量和大量对乙酰氨基酚过量的最有效治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Changes in the commercialization of nonprescription drugs have made large quantities of paracetamol available to individuals, resulting in larger overdoses than previously observed. Although most patients with paracetamol overdose can be managed with acetylcysteine, patients with a massive overdose may become critically ill earlier and fail standard antidotal therapy. Several strategies are proposed for the management of these patients, including using increased doses of acetylcysteine, extracorporeal removal, and fomepizole. However, the benefits of these strategies remain largely theoretical, with sparse evidence for efficacy in humans.

METHODS: This cross-sectional study surveys international practice patterns of medical toxicology providers regarding the management of a hypothetical patient with a massive paracetamol overdose.

RESULTS: A total of 342 responses from 31 different nations were obtained during the study period. Sixty-one percent of providers would have increased their acetylcysteine dosing when treating the hypothetical massive overdose. Thirty percent of respondents recommended an indefinite infusion of acetylcysteine at 12.5 mg/kg/hour after the bolus dose, whereas 20 percent recommended following the "Hendrickson" protocol, which advocates for a stepwise increase in acetylcysteine dosing to match high paracetamol concentrations at the 300 mg/L, 400 mg/L, and 600 mg/L lines on the Rumack-Matthew nomogram. Ten percent of respondents stated they would have given "double dose acetylcysteine" but did not specify what that entailed. Forty-seven percent of respondents indicated that they would have given fomepizole, and 28 percent of respondents recommended extracorporeal removal.

DISCUSSION: Our survey study assessed the approach to a hypothetical patient with a massive paracetamol overdose and demonstrated that, at minimum, most respondents would increase the dose of acetylcysteine. Additionally, almost half would also include fomepizole, and nearly one-third would include extracorporeal removal.

CONCLUSIONS: There is considerable international variation for the treatment of both non-massive and massive paracetamol overdoses. Future research is needed to identify and standardize the most effective treatment for both non-massive and massive paracetamol overdoses.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Mohan S, Bloom J, Kerester S, et al. An international survey of the treatment of massive paracetamol overdose in 2023. Clin Toxicol (Phila). 2023. PMID: 38112311. doi:10.1080/15563650.2023.2286922

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。